You are here

  • Home
  • Archive
  • Volume 76, Issue 8
  • A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

Article metrics

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise report
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

 

Online download statistics by month:

Online download statistics by month: May 2017 to November 2023

AbstractFullPdf
May 20172297417385
Jun 20174920130141
Jul 20176039198186
Aug 20176958176160
Sep 20176153122117
Oct 20176682133122
Nov 2017490412198
Dec 2017667712585
Jan 2018606210489
Feb 201829306549
Mar 2018233713948
Apr 2018268411733
May 201874416241
Jun 2018103377041
Jul 2018674910443
Aug 201845826739
Sep 201837585346
Oct 201841154625
Nov 201831545952
Dec 201829063129
Jan 201925184331
Feb 201922124824
Mar 201920463724
Apr 201934495238
May 201928333428
Jun 201920322714
Jul 201915575229
Aug 201910652721
Sep 20199542917
Oct 201913314137
Nov 201912262723
Dec 201911822929
Jan 202010361915
Feb 20209613620
Mar 20208534528
Apr 20205953018
May 20206742314
Jun 202010423514
Jul 2020610189
Aug 20205033015
Sep 20203911213
Oct 20203942616
Nov 2020344358
Dec 20204562418
Jan 20214623217
Feb 20214274229
Mar 20213121223
Apr 20213731710
May 20212571311
Jun 2021982612
Jul 202199179
Aug 2021932110
Sep 20211092510
Oct 2021283306
Nov 2021316308
Dec 2021303133
Jan 202237156
Feb 202226084
Mar 2022438209
Apr 20224131810
May 2022397178
Jun 2022214146
Jul 20222043819
Aug 2022242319
Sep 2022234345
Oct 20222612111
Nov 2022179145
Dec 2022127253
Jan 20232101612
Feb 2023224217
Mar 202325896
Apr 2023124142
May 2023186115
Jun 202318491
Jul 202314171
Aug 2023192125
Sep 2023145141
Oct 2023272141
Nov 2023209204
Total14056637882620